ARM’s Silent Victory: The Hidden Chip Powering NVIDIA’s Next Generation

The First Real Crack: What Happens When AI Buyers Refuse to Pay the Bill?

In this episode, the team discusses a pivotal week in the technology sector where a new market regime has emerged, punishing record-breaking corporate earnings whenever they fail to surpass vertical expectations. They break down the massive hardware shifts coming out of Computex, including NVIDIA’s next-gen Vera Rubin platform, its tactical push into ARM-based AI PCs, and the massive valuation ripples felt by custom silicon players like Marvell and Broadcom. The team also explores the decoupling of cybersecurity from the broader "SaaS apocalypse," alongside a deeper look into Alphabet’s unprecedented $85 billion equity raise to fund an aggressively accelerating CapEx cycle. Finally, they analyze the historic public market re-openings of tech giants like SpaceX and Anthropic, weighing this massive capital recycling wave against emerging warnings from OpenAI that customers are beginning to balk at the real-world costs of running these models.   This podcast is prepared and distributed by AMI Asset Management (AMI), an SEC-registered investment adviser (registration does not imply a certain level of skill or training). The information contained herein, and the opinions expressed are those of AMI as of the date of writing, prepared solely for general informational and discussion purposes. The information contained in this podcast has been compiled by AMI from sources believed to be reliable; however, AMI does not make any representation as to their accuracy, completeness or correctness and does not accept liability for any loss arising from the use hereof. Such information and opinions are subject to change without notice due to changes in market or economic conditions and may not necessarily come to pass. References to specific securities are not intended as recommendations of said securities. Please note that some of the securities mentioned may be held in an AMI strategy or in personal accounts. The reader should not assume that any investments in securities, sectors and markets identified or described were or will be profitable. Investing entails risks, including possible loss of principal. Past performance is not a guide to future performance and future returns are not guaranteed. The investment strategies referenced may not be suitable or appropriate for all investors depending on their specific investment objectives and financial situation and potential investors should consult with their own financial professional before determining whether to invest in the strategy.

Rate Hikes Back on the Table? How a Supply Shock is Forcing the Fed's Hand

In this episode, the team discusses the macro forces driving the markets to all-time highs, examining the persistent debate around an AI tech bubble versus the sector's robust profitability. They explore a recent revival in software stocks, looming liquidity tests from upcoming high-profile tech IPOs, and imminent pricing and usage limit shifts for large language models. The team also breaks down the complex reality of global oil supply, analyzing a potential truce regarding the Strait of Hormuz against deep structural damage to domestic inventories and a cautious outlook from major energy producers. Finally, they look at how these supply shocks and elevated gas prices feed directly into a K-shaped economy, where historic lows in consumer sentiment contrast sharply with a market entirely propelled by high-income spending and historic tech infrastructure capex.   This podcast is prepared and distributed by AMI Asset Management (AMI), an SEC-registered investment adviser (registration does not imply a certain level of skill or training). The information contained herein, and the opinions expressed are those of AMI as of the date of writing, prepared solely for general informational and discussion purposes. The information contained in this podcast has been compiled by AMI from sources believed to be reliable; however, AMI does not make any representation as to their accuracy, completeness or correctness and does not accept liability for any loss arising from the use hereof. Such information and opinions are subject to change without notice due to changes in market or economic conditions and may not necessarily come to pass. References to specific securities are not intended as recommendations of said securities. Please note that some of the securities mentioned may be held in an AMI strategy or in personal accounts. The reader should not assume that any investments in securities, sectors and markets identified or described were or will be profitable. Investing entails risks, including possible loss of principal. Past performance is not a guide to future performance and future returns are not guaranteed. The investment strategies referenced may not be suitable or appropriate for all investors depending on their specific investment objectives and financial situation and potential investors should consult with their own financial professional before determining whether to invest in the strategy.

ARM’s Silent Victory: The Hidden Chip Powering NVIDIA’s Next Generation

In this episode, the team discusses a critical week of market-moving earnings across both the retail sector and the tech industry, anchored by a deeply insightful analysis of a massive report from NVIDIA. They break down a stark disconnect in the retail space, where consumer sentiment has sunk to historic lows but companies like Target, Walmart, and off-price leaders are managing to deliver highly resilient sales numbers despite mounting pressures from gas prices and the rising cost of everyday goods. Shifting focus to technology, the team dissects how NVIDIA is cleverly reorganizing its business to build a moat against its own customers while pioneering a new structural demand leg for custom ARM-based CPUs to fuel autonomous AI agents. Finally, they look upstream at the entire semiconductor supply chain, mapping out how deliberate production limits at foundational bottleneck players like Taiwan Semi and ASML are serving as a structural barrier that keeps the current AI infrastructure boom from transforming into a classic dot-com-style bubble over build.   This podcast is prepared and distributed by AMI Asset Management (AMI), an SEC-registered investment adviser (registration does not imply a certain level of skill or training). The information contained herein, and the opinions expressed are those of AMI as of the date of writing, prepared solely for general informational and discussion purposes. The information contained in this podcast has been compiled by AMI from sources believed to be reliable; however, AMI does not make any representation as to their accuracy, completeness or correctness and does not accept liability for any loss arising from the use hereof. Such information and opinions are subject to change without notice due to changes in market or economic conditions and may not necessarily come to pass. References to specific securities are not intended as recommendations of said securities. Please note that some of the securities mentioned may be held in an AMI strategy or in personal accounts. The reader should not assume that any investments in securities, sectors and markets identified or described were or will be profitable. Investing entails risks, including possible loss of principal. Past performance is not a guide to future performance and future returns are not guaranteed. The investment strategies referenced may not be suitable or appropriate for all investors depending on their specific investment objectives and financial situation and potential investors should consult with their own financial professional before determining whether to invest in the strategy.

The Peptide Revolution: Why “Ozempic” Is Just the Tip of the Iceberg

In this episode, the team discusses the rapid evolution ofthe anti-obesity medication market, tracing the history of GLP-1s from their origins in Gila monster saliva to the current dominance of brands like Ozempic and Mounjaro. They analyze the shifting landscape of drug delivery, includingthe rise of oral alternatives and upcoming "triple-action"medications that aim to balance higher efficacy with more manageable side-effect profiles. The team also explores the broad downstream impacts these drugs are having on the economy, from shifting consumer food habits and restaurant portion sizes to new medical frontiers like muscle preservation and the treatment of sleep apnea. Finally, they weigh the long-term potential of this sector as it expands toward a target market of over 35% of the U.S. population, signaling a decade of significant structural change for both the pharmaceutical and consumer goods industries.   This podcast is prepared and distributed by AMI Asset Management (AMI), an SEC-registered investment adviser (registration does not imply a certain level of skill or training). The information contained herein, and the opinions expressed are those of AMI as of the date of writing, prepared solely for general informational and discussion purposes. The information contained in this podcast has been compiled by AMI from sources believed to be reliable; however, AMI does not make any representation as to their accuracy, completeness or correctness and does not accept liability for any loss arising from the use hereof. Such information andopinions are subject to change without notice due to changes in market or economic conditions and may not necessarily come to pass. References to specific securities are not intended as recommendations of said securities.Please note that some of the securities mentioned may be held in an AMI strategy or in personal accounts. The reader should not assume that any investments in securities, sectors and markets identified or described were or will be profitable. Investing entails risks, including possible loss of principal. Past performance is not a guide to future performance and futurereturns are not guaranteed. The investment strategies referenced may not be suitable or appropriate for all investors depending on their specific investment objectives and financial situation and potential investors should consult with their own financial professional before determining whether to invest in the strategy.

The "K" is Breaking: Why Middle-Class Value Brands are Stalling

In this episode, the team discusses the emerging "cracks" in the consumer economy as persistent inflation and a spike in gas prices begin to drive significant demand destruction. They analyze a "tale of two days" in earnings reports, where early optimism for a K-shaped recovery was met with sobering updates from value leaders like McDonald's and Planet Fitness, suggesting the low-end consumer is increasingly stretched to their limit. The team also explores the disparate impacts of GLP-1 weight loss drugs on various sectors, from potential "super cycles" in apparel and skincare to further headwinds for traditional restaurant chains. Ultimately, the discussion highlights the precarious state of consumer sentiment—which has reached levels of pessimism not seen since the Great Financial Crisis—and the long-term risks posed by sustained energy costs.   This podcast is prepared and distributed by AMI Asset Management (AMI), an SEC-registered investment adviser (registration does not imply a certain level of skill or training). The information contained herein, and the opinions expressed are those of AMI as of the date of writing, prepared solely for general informational and discussion purposes. The information contained in this podcast has been compiled by AMI from sources believed to be reliable; however, AMI does not make any representation as to their accuracy, completeness or correctness and does not accept liability for any loss arising from the use hereof. Such information and opinions are subject to change without notice due to changes in market or economic conditions and may not necessarily come to pass. References to specific securities are not intended as recommendations of said securities. Please note that some of the securities mentioned may be held in an AMI strategy or in personal accounts. The reader should not assume that any investments in securities, sectors and markets identified or described were or will be profitable. Investing entails risks, including possible loss of principal. Past performance is not a guide to future performance and future returns are not guaranteed. The investment strategies referenced may not be suitable or appropriate for all investors depending on their specific investment objectives and financial situation and potential investors should consult with their own financial professional before determining whether to invest in the strategy.